JPH0894618A - Simple measuring method and simple measuring device - Google Patents
Simple measuring method and simple measuring deviceInfo
- Publication number
- JPH0894618A JPH0894618A JP25605394A JP25605394A JPH0894618A JP H0894618 A JPH0894618 A JP H0894618A JP 25605394 A JP25605394 A JP 25605394A JP 25605394 A JP25605394 A JP 25605394A JP H0894618 A JPH0894618 A JP H0894618A
- Authority
- JP
- Japan
- Prior art keywords
- labeled
- antibody
- immunological
- colored latex
- latex particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
(57)【要約】
【目的】 本発明は検査結果に対する判定の誤認を避け
ることを目的に、色調の異なる着色ラテックス粒子を複
数用い、イムノクロマトグラフ支持体上で別々な位置
に、それぞれ単一の色調で示す免疫学的診断方法と、い
つでも、どこでも、誰にでも実施できる簡易測定装置を
提供する。
【構成】 本発明は簡便かつ迅速に、免疫学的に異なる
複数の物質(インジケーター物質を含む)を2種類以上
の色調の異なる着色ラテックス粒子を用い、同一支持体
上の別々な位置で別々の色調で着色させて検出する方法
と本方法に従って作製する試験片およびその試験片を装
着した検出部および検体溶解部、検体採取部の3機能部
品からなり、一体化あるいは連結でき、免疫学的反応終
了後、検出部分を切り離すことができる簡易測定装置よ
り構成される。(57) [Summary] [Purpose] The present invention uses a plurality of colored latex particles having different color tones for the purpose of avoiding misjudgment of judgments on test results, and a single latex is used at different positions on an immunochromatographic support. (EN) An immunological diagnostic method indicated by color tone and a simple measuring device that can be performed by anyone, anytime, anywhere. According to the present invention, a plurality of immunologically different substances (including an indicator substance) are simply and quickly used by using colored latex particles having two or more kinds of different color tones, at different positions on the same support. It is composed of a method of detecting by coloring with a color tone, a test piece prepared according to this method, and a detection section equipped with the test piece, a sample dissolving section, and a sample collecting section, which can be integrated or connected and have an immunological reaction. After completion, it consists of a simple measuring device that can separate the detection part.
Description
【0001】[0001]
【産業上の利用分野】本発明は簡易な測定方法および簡
易な測定装置に関し、詳しくは試料中の標的の存在の有
無を決定する特異的な結合反応を用いる分析方法を応用
して分析対象物を簡便かつ迅速に測定する方法および装
置に関する。本発明の対象とされる試料としては、例え
ば、血清、血漿、全血、尿、糞便などすべての生物学的
流体およびその産物である。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a simple measuring method and a simple measuring device, and more specifically, it applies an analytical method using a specific binding reaction for determining the presence or absence of a target in a sample to be analyzed. The present invention relates to a method and a device for easily and quickly measuring a. Examples of samples to which the present invention is applicable include all biological fluids such as serum, plasma, whole blood, urine, and feces, and products thereof.
【0002】[0002]
【従来の技術】従来、微粒子を用いたイムノクロマトグ
ラフ法にはコロイド状金属粒子、コロイド状金属酸化物
粒子、さらにはコロイド状非金属粒子が標識粒子として
広く用いられており、特開昭55−15100および特
開昭64−35372に記載されているごとくすでに公
知である。また、近年、合成高分子化学分野の発展と共
に染色された合成高分子ラテックス粒子の技術開発には
めざましいものがあり、この微粒子を用いるイムノクロ
マトグラフ法も開発され、特開平6−18032および
特開平6−160388に記載されているごとくすでに
公知の方法である。本法を利用した製品には妊娠診断薬
(クリアブルーワンステップ〈登録商標〉ユニパス社
製)によって代表される。2. Description of the Related Art Conventionally, colloidal metal particles, colloidal metal oxide particles and colloidal non-metal particles have been widely used as labeling particles in immunochromatography using fine particles. It is already known as described in JP 15100 and JP-A-64-35372. Further, in recent years, there has been a remarkable technological development of dyed synthetic polymer latex particles with the development of the field of synthetic polymer chemistry, and an immunochromatographic method using these fine particles has also been developed, which is disclosed in JP-A-6-18032 and JP-A-6-18032. The method is already known as described in -160388. The products using this method are represented by pregnancy diagnostic agents (Clear Blue One Step <registered trademark> Unipass).
【0003】従来のイムノクロマトグラフ法を利用する
検出方法においては、上述の妊娠診断薬にみられるよう
に1種類の着色コロイド粒子や1種類の着色ラテックス
粒子を用いて、抗原となるヒトゴナドトロピン(hC
G)を検出して所期目的を達成するものであった。しか
しながら、本発明の最も重要な特許構成要件の1つであ
る『色調の異なる着色ラテックスを用い、同一支持体上
において同時に簡便、迅速、明確に測定する』と云う方
法は未だ開示された例がない。In the conventional detection method using immunochromatography, human gonadotropin (hC) as an antigen is prepared by using one kind of colored colloidal particles and one kind of colored latex particles as seen in the above-mentioned pregnancy diagnostics.
G) was detected to achieve the intended purpose. However, one of the most important patent requirements of the present invention, "method of using colored latexes having different color tones and simultaneously, simply, rapidly and clearly measuring on the same support", has been disclosed as an example. Absent.
【0004】また、本発明の簡易測定装置は検体溶解
部、検体採取部および検出部の3機能を有しそれぞれの
機能が分割可能な部品より構成されているのが特徴であ
る。(図3) 測定時はそれぞれの部品を一体化または連結して使用
し、測定後は検出部のみを取り外すことができるので、
極めて簡単な操作で目的が達成され、衛生的、かつ、検
査結果の保存などすぐれた特徴を有する簡易測定装置は
未だ開示された例がない。Further, the simple measuring device of the present invention is characterized in that it has three functions of a sample dissolving section, a sample collecting section and a detecting section, and is composed of parts which can be divided into respective functions. (Fig. 3) When measuring, each part can be integrated or connected, and after measurement, only the detection part can be removed.
There is no disclosed example of a simple measuring device that achieves the purpose with an extremely simple operation, is hygienic, and has excellent characteristics such as storage of test results.
【0005】[0005]
【発明が解決しようとする課題】従来、イムノクロマト
グラフ法を用いた体外診断薬分野への応用として、現在
市販されている妊娠診断薬(クリアブルーワンステップ
〈登録商標〉ユニパス社製)にみられるように、妊娠の
重要なマーカーとして、尿中のヒトゴナドトロピン ペ
プチドホルモンの検出でもって妊娠の有無を判定もしく
は診断の一助とする方法は体外診断薬の分野では操作が
簡単、迅速、かつ、正確な情報が得られる点で画期的な
製品である。しかしながら、クリアブルーワンステップ
など市販のイムノクロマトグラフ法を用いた妊娠診断薬
では尿中のヒトゴナドトロピンを検出するラインと反応
終了を示す2本のラインで示され、これらのラインを示
す色調が例えば、ブルーなどの同一色であるため、使用
者は薬局、薬店あるいは医師による充分な説明あるいは
能書などを充分理解していなければ、しばしば誤認ある
いは判定結果を違えることにもなりうるもので大きな社
会問題にもなりかねない。Conventionally, as an application to the field of in vitro diagnostics using immunochromatography, it can be found in pregnancy diagnostics (Clear Blue One Step <registered trademark> Unipass) currently on the market. As described above, as an important marker of pregnancy, a method of determining the presence or absence of pregnancy or assisting the diagnosis by detecting human gonadotropin peptide hormone in urine is easy to operate, quick, and accurate in the field of in vitro diagnostics. It is an epoch-making product in that information can be obtained. However, a pregnancy diagnostic drug using a commercially available immunochromatographic method such as Clear Blue One Step is shown by a line for detecting human gonadotropin in urine and two lines indicating the end of reaction, and the color tone indicating these lines is, for example, Since it is the same color such as blue, if the user does not fully understand the sufficient explanations or written descriptions by the pharmacy, drugstore, or doctor, it may cause misidentification or the judgment result to be a big social problem. It can be.
【0006】特に、我が国においては、妊娠診断薬は一
般用の体外診断薬として薬局、薬店で購入が可能である
ため、本製品は、いつでも、どこでも、誰にでも操作が
でき、結果が間違うことなく明確に判定できることが最
も重要なところである。本発明はこの点を特に重視し、
2種類以上の色調の異なる着色ラテックス粒子を用い、
いつでも、どこでも、誰にでも操作が可能な簡易測定装
置を考案し、結果の判定については陰性側および陽性側
が明確に区別できる方法を開示するものである。例え
ば、実施例2の1態様に従って説明すると、検査結果が
陰性の場合は青色のインジケーターライン1本で示さ
れ、陽性の場合は青色のインジケーターラインと、例え
ば、ヘモグロビンが検出されたときに現われる赤色のラ
インの2本で示される。Especially in Japan, since the pregnancy diagnostic drug can be purchased as an in-vitro diagnostic drug for general use at pharmacies and drug stores, this product can be operated by anyone anytime, anywhere, and the result is wrong. It is the most important thing to be able to make a clear decision without any. The present invention attaches particular importance to this point,
Using colored latex particles of two or more different colors,
It discloses a method of devising a simple measuring device that can be operated by anyone at any time, anywhere, and by clearly distinguishing the negative side and the positive side in the determination of results. For example, according to one aspect of Example 2, when the test result is negative, it is indicated by one blue indicator line, when it is positive, the indicator line is blue and, for example, the red color that appears when hemoglobin is detected. Indicated by two of the lines.
【0007】[0007]
【課題を解決するための手段】以下、本発明の完成に至
った経緯および課題を解決するための手段について詳細
に述べる。近年、抗原−抗体反応を利用して、目的とす
る免疫学的能力を有する物質の検出は医療分野を中心と
してすばらしい進歩を遂げている。そもそも、抗原−抗
体反応そのものは生体内あるいは自然界で必然性に応じ
て反応が生じているものであり、その原理・仕組みを人
類が解明しつつあることによって多大な恩恵を受けてい
る。特に医療分野では診断の予測あるいは診断の一助と
して大きな意義をもっており、血液、尿、糞便、体液な
どを被検液として用いるため、患者への苦痛を与えるこ
となく検査できる点が利点である。[Means for Solving the Problems] The background to the completion of the present invention and the means for solving the problems will be described in detail below. In recent years, the detection of a substance having a desired immunological ability by utilizing an antigen-antibody reaction has made great progress mainly in the medical field. In the first place, the antigen-antibody reaction itself is a reaction occurring in the living body or the natural world according to necessity, and it is greatly benefited by the fact that human beings are elucidating the principle and mechanism. Particularly in the medical field, it has great significance as a prediction of diagnosis or as an aid to diagnosis, and since blood, urine, feces, body fluids, etc. are used as test liquids, it is advantageous that the test can be performed without causing pain to the patient.
【0008】本来、抗原−抗体反応とは「錠前と鍵穴」
の関係にたとえられるごとく、免疫学的な反応に授かる
物質と対応する物質との結合によって特異的な結合体を
形成するものであって、その大部分は共有結合のような
強い結合ではなく、極く弱い結合を保持し成立してい
る。このことから人為的に抗原−抗体反応複合体より抗
原あるいは抗体をそれぞれ単独に回収することができ
る。したがって、抗原−抗体反応系には、丁度、酵素に
対する基質の関係と同様にアフィニティー(親和性)の
概念が成立する訳である。すなわち、目的とする酵素を
単離・精製したいときは、目的とする酵素の基質をあら
かじめ樹脂(担体)に固定しておき、目的とする酵素の
みが基質と結合するので、水洗後、溶離液で溶出するこ
とによって一挙に高純度の酵素が回収できる。このよう
な単離・精製手段をアフィニティークロマトグラフィー
と命名されている。本法の検出手段として用いるイムノ
クロマトグラフィーは、クロマトグラフィーの体系から
みると、まさしくアフィニティークロマトグラフィーに
包括されるべきものであって、一般にクロマトグラフィ
ーの名称で述べられている溶質と溶媒との分配係数の差
でもって物質を分離・精製するという手段とは異なるも
のである。Originally, the antigen-antibody reaction is "lock and keyhole"
As is similar to the relationship of, a specific binding substance is formed by the binding between a substance that is involved in an immunological reaction and a corresponding substance, most of which are not strong bonds such as covalent bonds, It holds with a very weak bond. From this, it is possible to artificially recover the antigen or the antibody individually from the antigen-antibody reaction complex. Therefore, in the antigen-antibody reaction system, just like the relationship of the substrate to the enzyme, the concept of affinity is established. That is, when you want to isolate and purify the target enzyme, the substrate of the target enzyme is immobilized on the resin (carrier) in advance, and only the target enzyme binds to the substrate, so after washing with water, the eluent High-purity enzyme can be recovered all at once by elution with. Such an isolation / purification means is called affinity chromatography. The immunochromatography used as the detection means of this method should be included in the affinity chromatography in view of the chromatographic system, and the partition coefficient between the solute and the solvent, which is generally described in the name of chromatography, is used. It is different from the means of separating and purifying substances by the difference of.
【0009】すなわち、あらかじめ支持体上に固相化し
た抗原もしくは抗体が存在し、支持体の下端に着色した
標識微粒子が水などの溶媒を媒体として支持体のもつ毛
細管現象の作用で順次拡散・移動し、その際、免疫的に
形成せしめた複合体−着色標識粒子によって、先の抗原
もしくは抗体を固相化しておいた位置にその複合体−微
粒子が到達し、その場所で特異的に抗原−抗体反応を生
じ、着色シグナルとして目視的に観察することができる
ものである。That is, an antigen or antibody immobilized in advance on a support is present, and colored labeled fine particles at the lower end of the support are sequentially diffused by the action of capillarity of the support using a solvent such as water as a medium. Upon migration, the complex-colored labeled particles immunologically formed reach the position where the previous antigen or antibody was immobilized, and the complex-fine particles specifically reach the position. -An antibody reaction occurs, which can be visually observed as a colored signal.
【0010】以上のようなアフィニティークロマトグラ
フィーの原理に基づいて、本法をさらに発展せしめ鋭意
研究を重ねた結果、以下、本発明の完成に至った。本特
許記載のイムノクロマトグラフィーに用いる微粒子には
色調の異なる別々のコロイド状金属粒子、あるいは色調
の異なる別々のコロイド状金属酸化物粒子、さらには色
調の異なる別々のコロイド状非金属粒子を用いることが
できるが、色調の多様性やイムノクロマトグラフィー展
開後の鮮明さを考慮すると合成高分子ラテックス粒子が
好ましい。イムノクロマトグラフィーに用いる市販の合
成高分子ラテックス粒子は当業者が本クロマトグラフィ
ーを最適な条件で実施できるように設計されており、ま
た、現在の高分子化学の合成技術水準からみても、高い
水準の技術を駆使した高品質の製品である。ちなみに、
本発明者らの本特許記載の実施例における使用実績から
みても、抗原もしくは抗体による標識粒子の調製、標識
後の乾燥工程による安定性さらには支持体上での拡散・
移動性および固相化位置における着色の鮮明性などに何
ら問題を生じるものではない。このような高品質のラッ
テクス粒子は当業者が容易に入手することができる。Based on the above-mentioned principle of affinity chromatography, the present method was further developed and earnestly studied, and as a result, the present invention was completed. It is possible to use different colloidal metal particles having different colors, or different colloidal metal oxide particles having different colors, and further different colloidal non-metal particles having different colors as the fine particles used in the immunochromatography described in this patent. However, synthetic polymer latex particles are preferable in consideration of the variety of color tones and the sharpness after development by immunochromatography. Commercially available synthetic polymer latex particles used for immunochromatography are designed so that those skilled in the art can carry out the chromatography under the optimal conditions, and also in view of the current synthesis technology level of polymer chemistry, it is of a high standard. It is a high-quality product that makes full use of technology. By the way,
From the results of use in the examples described in the present patent by the inventors, preparation of labeled particles with an antigen or antibody, stability by a drying step after labeling, and further diffusion on a support
It does not cause any problems in terms of mobility and sharpness of coloring at the solid-phased position. Such high quality latex particles can be easily obtained by those skilled in the art.
【0011】例えば、ブルーラテックス粒子分散液、グ
リーンラテックス粒子分散液およびレッドラテックス粒
子分散液の色調の異なったラテックス粒子はポリマーラ
ボラトリー社より容易に入手することができる。その
他、ローヌプーラン社、セラダイン社、インターナショ
ナルダイナミクスコーポレーション社および積水化学工
業株式会社などからも入手が可能である。また、イムノ
クロマトグラフ用のラテックス粒子の大きさは0.05
〜5μmの範囲で市販されており、この範囲内の任意の
大きさで使用も可能であるが、好ましくは標識する抗原
もしくは抗体によって、適宜、粒子の大きさを選択する
ことも感度・精度の上からも重要であり、通常0.45
μmの大きさが適している。For example, latex particles having different color tones of blue latex particle dispersion, green latex particle dispersion and red latex particle dispersion can be easily obtained from Polymer Laboratories. In addition, it is also available from Rhone Poulin, Ceradaine, International Dynamics Corporation and Sekisui Chemical Co., Ltd. The size of latex particles for immunochromatography is 0.05
It is commercially available in the range of up to 5 μm, and it can be used in any size within this range, but it is preferable to select the particle size appropriately depending on the antigen or antibody to be labeled. Also important from the top, usually 0.45
A size of μm is suitable.
【0012】次に本発明に用いるイムノクロマトグラフ
ィーに使用する支持体について説明する。本発明に有用
なイムノクロマトグラフィーに使用する支持体は毛細管
現象を起こす作用を有し、かつ、合成高分子標識ラテッ
クス粒子と検出しようとする物質との複合体がイムノク
ロマトグラフ用展開剤、例えば、水や緩衝液などですみ
やかに拡散・移動できるような支持体であれば良い。一
般にイムノクロマトグラフィーに使用する担体としてガ
ラス繊維状のシート、濾紙あるいはナイロンシート、ニ
トロセルロースシートなどが使用できるが、本発明に好
適なシートはニトロセルロースシートである。ニトロセ
ルロースシートはBAS−85(Schleicher
& Schuell社製)、HAHY(Millip
ore社製)として市販されており、当業者は容易に入
手することができる。Next, the support used in the immunochromatography used in the present invention will be described. The support used in the immunochromatography useful in the present invention has an action of causing a capillary phenomenon, and a complex of a synthetic polymer labeled latex particle and a substance to be detected is a developing agent for immunochromatography, for example, water. Any support can be used so long as it can be diffused and moved quickly with or buffer solution. Generally, a glass fiber sheet, a filter paper, a nylon sheet, a nitrocellulose sheet or the like can be used as a carrier used for immunochromatography, and the sheet suitable for the present invention is a nitrocellulose sheet. Nitrocellulose sheet is BAS-85 (Schleicher
& Schuell), HAHY (Millip
ore), and can be easily obtained by those skilled in the art.
【0013】次に支持体上へ複数の抗原もしくは抗体の
固相化方法について説明する。本発明の完成に有用な支
持体としてニトロセルロースシートを選ぶことができ、
本支持体へ複数の抗原もしくは抗体を固相化するに当た
っては、実施例に記載した態様を例にあげて具体的に説
明すれば良く理解することができる。Next, a method for immobilizing a plurality of antigens or antibodies on a support will be described. A nitrocellulose sheet can be selected as a support useful in completing the invention,
The immobilization of a plurality of antigens or antibodies on the present support can be well understood by specifically explaining it by taking the embodiment described in Examples as an example.
【0014】本発明のインジケーター物質とは被検液中
に存在する測定しようとする物質およびその物質と免疫
学的に反応する能力のある物質と交差反応を示さない物
質であれば本発明に用いることができるので、特に限定
されないが、通常、他動物のイムノグロブリンが好適で
ある。また、赤色のラインは交通標識の信号機の色と同
様な解釈であり、警告あるいは異常を示し、青色のライ
ンのみの場合は異常が認められなかったことを示す意味
である。したがって、このように色調の異なった色で陰
性あるいは陽性を区別することは、誰にでも理解されや
すいので誤った判定が避けられ安心して使用することが
できる。The indicator substance of the present invention is used in the present invention as long as it is a substance present in a test liquid to be measured and a substance that does not cross-react with a substance capable of immunologically reacting with the substance. However, it is not particularly limited, and immunoglobulins of other animals are usually preferable. Further, the red line has the same interpretation as the traffic signal color of the traffic sign, and indicates a warning or abnormality, and the blue line alone means that no abnormality is recognized. Therefore, since it is easy for anyone to distinguish negative or positive by colors having different color tones in this way, erroneous determination can be avoided and it can be used with confidence.
【0015】すなわち、通常、イムノクロマトグラフィ
ーを行うのに適した任意の大きさに整えたニトロセルロ
ース支持体をあらかじめ準備し、本支持体の任意に選ん
だ一定のゾーンに第1の抗原もしくは抗体(実施例2で
は抗ウサギIgGポリクロナール抗体)を塗布またはス
プレーで散布し、上記以外のゾーンに第2の抗原もしく
は抗体(実施例2では抗ヒトヘモグロビン抗体)を塗布
またはスプレーで散布するなどして固相化する。また第
3、第4、第5などの抗原もしくは抗体の固相化も同様
に為し得る。なお、ここで支持体に固相化した抗原もし
くは抗体は後のイムノクロマトグラフィーの展開によっ
て、それぞれ位置の異なった固相化したゾーンで抗原−
抗体反応を生じ着色する訳であるから、あらかじめ着色
の形状を設定しておくことが望ましい。That is, usually, a nitrocellulose support prepared in an arbitrary size suitable for carrying out immunochromatography is prepared in advance, and the first antigen or antibody (in the predetermined zone of the support is arbitrarily selected). In Example 2, an anti-rabbit IgG polyclonal antibody) is applied or sprayed, and the second antigen or antibody (anti-human hemoglobin antibody in Example 2) is applied or sprayed in a zone other than the above to solidify. To be compatible. Also, the solid phase immobilization of the third, fourth, fifth, etc. antigens or antibodies can be carried out in the same manner. Incidentally, here, the antigen or antibody immobilized on the support is subjected to the subsequent immunochromatographic development, and the antigen-antibody is immobilized on the immobilized zone at different positions.
It is desirable to set the coloring shape in advance because it causes an antibody reaction and causes coloring.
【0016】しかしながら、本発明においてはそれぞれ
のゾーンで色調の異なる着色を示すので着色の形状が
●、−、+、◎、×、△、…などのいかなる表示方法で
あっても許容できる。好ましくは、スポット状(●)ま
たはライン状(−)の表示が簡単、明瞭である。However, in the present invention, since the coloring is different in each zone, any shape of coloring, such as ●, −, +, ⊚, ×, Δ, ... Is acceptable. Preferably, the spot-shaped (●) or line-shaped (-) display is simple and clear.
【0017】次に、乾燥工程について説明する。通常の
乾燥は室温放置で良いが、必要であれば30〜50℃の
熱風による乾燥あるいは真空乾燥などの方法を適宜行っ
ても差支えはない。乾燥後、ニトロセルロース支持体上
の第1および第2あるいは第3、第4、第5などの抗原
もしくは抗体の固相化したゾーン以外の領域を不活化す
るために、別なタンパク質でもってマスキングすること
が通常行われている。一般にマスキング剤としては生理
食塩水に0.2%を溶解したカゼイン溶液あるいは1%
スキムミルク(DIFCO社製)、4%ブロックエース
(明治乳業社製)などを用いるが、使用する抗原または
抗体あるいは支持体の性質によって、その都度、適切な
マスキング剤を選択する必要がある。Next, the drying process will be described. Normal drying may be carried out at room temperature, but if necessary, drying with hot air at 30 to 50 ° C. or vacuum drying may be appropriately performed. After drying, masking with another protein to inactivate areas other than the solidified zone of the first and second or third, fourth, fifth, etc. antigens or antibodies on the nitrocellulose support. It is usually done. Generally, as a masking agent, a casein solution prepared by dissolving 0.2% in physiological saline or 1%
Skim milk (manufactured by DIFCO), 4% Block Ace (manufactured by Meiji Dairy Co., Ltd.) and the like are used, but it is necessary to select an appropriate masking agent each time depending on the properties of the antigen or antibody or the support to be used.
【0018】次に、合成高分子標識着色ラテックス粒子
の調製法ならびに装着方法について説明する。各々の色
調を有する別々のラテックス粒子にそれぞれ複数の抗原
もしくは抗体を標識するにあたっては、例えば、赤色の
ラテックス粒子には第1の抗原もしくは抗体、青色のラ
テックス粒子には第2の抗原もしくは抗体、さらに黄
色、あるいは緑色のラテックス粒子には第3、第4の抗
原もしくは抗体をそれぞれ個別に標識しておく。標識方
法は通常行われている方法であれば特に限定はしない
が、一般にはラテックス粒子と標識する物質を室温約1
時間位混和することによって達成できる。その後、各々
標識した着色ラテックス粒子を個別に遠心分離などの方
法またはミリポアフィルターによる吸引濾過法によって
集め、通常使用されている緩衝液、例えば、リン酸緩衝
液などでよく洗浄後、マスキング剤で各々の標識ラテッ
クス粒子を個別にマスキングしておく。マスキング剤は
先の支持体で抗原もしくは抗体の固相化後に用いたマス
キング剤と同様なもので良い。Next, a method for preparing and attaching the synthetic polymer-labeled colored latex particles will be described. In labeling different latex particles having respective colors with a plurality of antigens or antibodies, for example, red latex particles have a first antigen or antibody, blue latex particles have a second antigen or antibody, Furthermore, the yellow or green latex particles are individually labeled with the third and fourth antigens or antibodies. The labeling method is not particularly limited as long as it is a commonly used method, but generally, the latex particles and the substance to be labeled are kept at room temperature at about 1
It can be achieved by mixing the time. Thereafter, each labeled colored latex particle is individually collected by a method such as centrifugation or a suction filtration method using a Millipore filter, washed well with a commonly used buffer solution, for example, a phosphate buffer solution, etc., and then each masked with a masking agent. The labeled latex particles of are individually masked. The masking agent may be the same as the masking agent used after immobilization of the antigen or antibody on the support.
【0019】しかしながら、マスキング剤の選択は標識
に使用した抗原または抗体および支持体の性質によっ
て、その都度、適格か否かを判断する必要がある。この
ようにして各々、個別に標識し得た着色ラテックス粒子
を保存液に貯えておく。各々の標識着色ラテックス粒子
を保存した液より一定量ずつ取り出しよく混和後、よく
洗浄して不織布などの多孔性ポリマーに含浸させて凍結
乾燥を行う。これを支持体の一定の場所に装着すること
によって本発明の検出可能な試験片が完成する。なお、
標識ラテックス粒子の支持体への装着については特に限
定されるものではなく、標識ラテックス粒子を直接支持
体へ塗布する方法等も利用することができる。装着位置
についてはイムノクロマトグラフィーの展開方法によっ
て定まるもので、例えば展開が上昇法の場合には下端部
に、下降法の場合には上端に、水平方式の場合には両端
部のどちらか一方に、円形方式の場合には同心円の中心
部分に装着することになる。However, it is necessary to judge whether the masking agent is suitable or not depending on the properties of the antigen or antibody used for labeling and the support. The colored latex particles that have been individually labeled in this way are stored in a storage solution. A predetermined amount of each labeled colored latex particle is taken out from the stored solution, mixed well, thoroughly washed, impregnated with a porous polymer such as a nonwoven fabric, and freeze-dried. By mounting this on a fixed place of the support, the detectable test piece of the present invention is completed. In addition,
The attachment of the labeled latex particles to the support is not particularly limited, and a method of directly applying the labeled latex particles to the support can also be used. The mounting position is determined by the immunochromatography deployment method.For example, if the deployment method is the ascending method, it is at the lower end, if it is the descending method, it is at the upper end, and if it is the horizontal method, it is at either end. In the case of the circular system, it is attached to the center of the concentric circles.
【0020】本発明においては展開方法を特に限定する
ものではないが、通常、一般に行われている上昇法が望
ましい。この場合、試験者は装着した支持体部分を被検
液に浸すのみで展開できるので有利である。In the present invention, the developing method is not particularly limited, but an ascending method which is generally performed is desirable. In this case, it is advantageous that the tester can develop the support by only immersing the mounted support portion in the test liquid.
【0021】次に、試験片について説明する。(図1参
照) イムノクロマトグラフィーに関する試験片については、
すでに数多くの発明が開示されているので、特に本発明
で詳細に言及する必要はない。しかしながら、本発明の
方法が確実に、また正確に当事者によって容易に実施で
きる「証」としてその1例を記す。実施例に示した試験
片はニトロセルロースなど、使用しやすさなどを考慮し
て任意の長方形の大きさに裁断し支持体を作製する。支
持体の下端部分を被検液に浸して毛細管現象により水な
どの溶媒を媒体として微量に溶けている抗原もしくは抗
体を吸い上げ、ニトロセルロース支持体上部へ移動せし
める不活性材質から選ばれる部分を装着する。本不活性
な材質には一般に濾紙、ガラス繊維シート、メンブラン
フィルターシートなどが用いられる。ニトロセルロース
支持体の下端部分には先に説明した不織布上に載せた標
識混合着色ラテックス粒子の凍乾物(着色ラテックス粒
子標識物質凍乾担体)を一定の大きさに裁断したもの
を、例えば、両面テープなどで軽く固定しておくか、最
終的に試験片として組み終えた段階でセロテープなどで
圧着固定しても差支えがない。また、図1に示したごと
く、ニトロセルロース上のそれぞれ異なった位置にあら
かじめ複数の抗原もしくは抗体を固相化しておく。Next, the test piece will be described. (See Fig. 1) Regarding the test pieces for immunochromatography,
Since many inventions have already been disclosed, it is not necessary to particularly refer to the present invention in detail. However, one example will be given as a "proof" that the method of the present invention can be carried out reliably and accurately by the parties concerned. The test pieces shown in the examples are made of nitrocellulose or the like and cut into an arbitrary rectangular size in consideration of ease of use to prepare a support. Dip the lower end of the support into the test solution and use a capillary phenomenon to absorb a small amount of an antigen or antibody dissolved in a solvent such as water as a medium, and attach a part selected from an inert material that can move to the top of the nitrocellulose support. To do. As the inert material, filter paper, glass fiber sheet, membrane filter sheet, etc. are generally used. At the lower end of the nitrocellulose support, a lyophilized product of the labeled mixed colored latex particles (colored latex particle labeling substance lyophilized carrier) placed on the above-mentioned nonwoven fabric is cut into a certain size, for example, There is no problem even if it is lightly fixed with tape, etc., or pressure-bonded with cellophane tape etc. at the stage when it is finally assembled as a test piece. In addition, as shown in FIG. 1, a plurality of antigens or antibodies are immobilized in advance at different positions on nitrocellulose.
【0022】一方、ニトロセルロース支持体の上端部分
には、図1に示すごとく吸水性の担体を装着することに
よって、イムノクロマトグラフィーの展開が正確に、ま
た迅速に為し得るため、さらには展開し終えた後の液漏
れなどを防ぐ目的で本担体を装着しておくことが望まし
い。このような吸水性担体はアドバンテック東洋社製の
濾紙No.526やワットマン社製の17Cr,3MM
などが市販されており容易に入手することができる。以
上、このような簡単な試験片で本発明の方法を検証また
は実施することができる。On the other hand, by mounting a water-absorbing carrier on the upper end portion of the nitrocellulose support as shown in FIG. 1, the immunochromatography can be developed accurately and quickly, so that it can be further developed. It is desirable to mount this carrier for the purpose of preventing liquid leakage after finishing. Such a water-absorbent carrier is a filter paper No. manufactured by Advantech Toyo Co., Ltd. 526 and Whatman 17Cr, 3MM
Are commercially available and can be easily obtained. As described above, the method of the present invention can be verified or implemented with such a simple test piece.
【0023】本明細書において記載の都合上、検出すべ
き物質が抗原である場合には、例えば、ニトロセルロー
ス支持体上に検出すべき物質の一定部位を認識できる抗
体を固相化し、一方、合成高分子ラテックス粒子への標
識には先の抗体とは別な個所の抗原分子を認識できる抗
体であれば本発明の方法は達成できる。また、本発明は
上述とは逆に抗体の検出の場合には、固相化抗原−検出
すべき物質−検出すべき物質の抗体からなる系でもって
実施できることは当業者には容易に理解されよう。した
がって、本発明は検出すべき物質が抗原である場合だけ
に限定されず、抗体をも包含するものであり、表現とし
ては「抗原もしくは抗体」として記してあるが、どちら
か一方が定まればおのずから対応する他方が定まること
になり、「抗原」および「抗体」なる文字を適宜使い分
けることにより、本発明の方法を実施することができ
る。For the sake of convenience described in the present specification, when the substance to be detected is an antigen, for example, an antibody capable of recognizing a certain site of the substance to be detected is immobilized on a nitrocellulose support, while The method of the present invention can be achieved by labeling the synthetic polymer latex particles as long as the antibody can recognize an antigen molecule at a position different from the above antibody. In addition, it is easily understood by those skilled in the art that, contrary to the above, the present invention can be carried out in the case of detecting an antibody by a system composed of immobilized antigen-substance to be detected-antibody of substance to be detected. See. Therefore, the present invention is not limited to the case where the substance to be detected is an antigen, and also includes an antibody, and the expression is described as "antigen or antibody", but if either one is determined, Naturally, the other corresponding will be determined, and the method of the present invention can be carried out by appropriately using the letters "antigen" and "antibody".
【0024】次に簡易測定装置について説明する。本装
置の1例を図3に示したが、被検体が糞便など半固形の
場合あるいは尿、血液、など流体の場合はそれらの物性
に応じて、適宜、採取部分の形状を変える必要があるこ
とは自明である。被検体が半固形状の場合は、例えば、
スパイラル状の溝や、○リング状の窪み、スポット状の
窪みなどを設けることによって本目的が達成できる。一
方、尿や血液などの流体の場合には、例えば、採取部分
をスプーン状にしたり、一定量の液体が吸収できる濾紙
やガラス繊維シートなどの不活性なシートをはさみ込む
ことによって目的が達成できる。図3に示した本装置は
被検体が糞便であって、糞便中のヒトヘモグロビンを測
定する1形状を説明するが、本発明の装置はこれによっ
て必ずしも限定されるものではない。糞便の採取にあた
っては、検体採取部品と検出部品を連結して先端部分を
便に数ヶ所突き刺し、検体採取穴に便を容易に入れるこ
とができる。そのとき、他の部分についた便はトイレッ
トペーパーなどで拭き取り便の一定量を採取することが
可能である。便を採取した採取部先端で軽く押して検体
溶解部のシールを破り、そのまま、さらに押し込んで連
結密着させ、次いで一体化した簡易測定装置を上下に激
しく振り混ぜて便を溶解する。Next, the simple measuring device will be described. An example of this device is shown in FIG. 3, but if the subject is semi-solid such as feces or fluid such as urine or blood, it is necessary to change the shape of the sampling portion as appropriate according to the physical properties of the fluid. That is self-evident. When the subject is semi-solid, for example,
This object can be achieved by providing a spiral groove, a circle-shaped depression, a spot-shaped depression, or the like. On the other hand, in the case of a fluid such as urine or blood, the object can be achieved by, for example, forming the sampling portion into a spoon shape or sandwiching an inert sheet such as a filter paper or a glass fiber sheet capable of absorbing a certain amount of liquid. . The apparatus shown in FIG. 3 will be described as one shape for measuring human hemoglobin in feces when the subject is feces, but the apparatus of the present invention is not necessarily limited to this. When collecting feces, the sample collection component and the detection component can be connected to each other and the tip portion can be pierced into the stool at several places to easily insert the stool into the sample collection hole. At that time, the stool attached to the other part can be wiped off with a toilet paper or the like to collect a certain amount of the stool. Gently press the tip of the collection part where the stool was collected to break the seal of the sample dissolution part, and push it in as it is to bring it into close contact, and then shake the integrated simple measuring device vigorously up and down to dissolve the stool.
【0025】その後、一体化した簡易測定装置を水平に
保つことによって一定量の溶解液が検体取り込み口に入
り、この溶解液量でもって展開・移動せしめ、3〜5分
後に青色のラインと赤色のラインの2本が認められれば
陽性、青色のラインのみの場合には陰性であると容易に
判定することができる。また、検査結果の取り扱いにつ
いては、検出部を取り外すことができるので以下に示す
メリットがある。すなわち、簡易型の本装置は極めて簡
単な操作で目的が達成され、検査結果の保存または郵送
あるいは持ち運びが簡単であるため、従来、被検者が直
接外来に便を提出することを考えれば、極めて衛生的で
あり、被検者に対する精神面の苦痛が取り除かれ、さら
には、医療従事者へのバイオハザードの面からも極めて
メリットの大きい装置である。After that, by keeping the integrated simple measuring device horizontal, a fixed amount of the lysing solution enters the sample intake port, and is developed and moved by this lysing solution amount, and after 3 to 5 minutes, a blue line and a red line. It is possible to easily judge as positive when two of the lines are observed and negative when only the blue line is present. Further, regarding the handling of the inspection result, since the detection unit can be removed, there are the following merits. That is, since the simple type device achieves the purpose by an extremely simple operation and is easy to store, mail or carry the test results, conventionally, considering that the subject directly submits a stool to an outpatient, The device is extremely hygienic, eliminates mental distress to the subject, and is extremely advantageous in terms of biohazard to medical personnel.
【0026】[0026]
【実施例】以下に実施例をあげて本発明をさらに詳細
に、具体的に説明するが、本発明の方法および装置につ
いてはこれらの実施例によって何ら限定されるものでは
ない。 実施例1 ヘモグロビン、トランスフェリンの検出方法The present invention will be described in more detail and concretely with reference to the following examples, but the method and apparatus of the present invention are not limited to these examples. Example 1 Method for detecting hemoglobin and transferrin
【0027】(1)抗ヒトヘモグロビンモノクロナール
抗体の作製 2回結晶ヒトヘモグロビン(Sigma社製)を滅菌蒸
留水に溶解し、10mg/mlのヒトヘモグロビン溶液
を調製した。次にヒトヘモグロビン溶液とFreund
のコンプリートアジュバントを等量混合しオイルエマル
ジョンとした。これをBALB/cAマウス(BALB
/cA jcl,7週齢、雌)の背部皮下に0.2ml
ずつ投与した。初回免疫後、7日目と16日目に追加免
疫を行い、さらに細胞融合3日前にヒトヘモグロビン溶
液を0.25mg/0.2mlずつ腹腔内に投与した。
最終免疫から3日目のマウス脾細胞とミエローマ細胞
(P3x63−Ag−6,5,3)を10:1の割合で
50%ポリエチレングリコール4000を用いて融合
し、HAT培地により選択した。細胞融合後、14日目
に培養上清のヒトヘモグロビンに対する抗体活性をEI
A法により測定した。測定方法はヒトヘモグロビン10
0μg/mlで固相化した96穴EIAプレート(コー
スター社製)を用い融合細胞の培養液200μlを添加
した。その後、37℃、1時間反応後、洗浄を行いペル
オキシダーゼ標識抗マウスIgG(Cappel社製、
1:500)200μlを添加した。洗浄後、基質液
(0.1M O−フェニレンジアミンと0.012%過
酸化水素水)を各ウエルに200μlずつ添加し、室温
で5分間反応させた。反応後、各ウエルに4N硫酸50
μlずつ添加し酵素反応を停止した。次に492nmに
おける吸光値を測定し、ヒトヘモグロビンに反応するク
ローンを限界希釈法により2回クローニングを行った。
その結果、クローニング後に腹水として得られたモノク
ロナール抗体は10クローンであった。これらの得られ
た各々の腹水1mlをPBS1mlで2倍に希釈し、飽
和硫酸アンモニウム2mlを滴加して4℃、4時間放置
した。その後、3,000rpm,20分間遠心分離し
沈査をPBS(リン酸緩衝生理食塩液)2mlに浮遊し
透析を行った。この中で反応性の良い2クローン(K−
6,K−8)を選択し以下の試験に用いた。なお、2ク
ローンのイムノグロブリン サブクラスはIgG1 ,L
鎖はカッパー型であった。(1) Anti-human hemoglobin monoclonal
Preparation of Antibody Double-crystal human hemoglobin (manufactured by Sigma) was dissolved in sterile distilled water to prepare a 10 mg / ml human hemoglobin solution. Next, human hemoglobin solution and Freund
An equal amount of the complete adjuvant of 1. was mixed to obtain an oil emulsion. This is a BALB / cA mouse (BALB
/ CA jcl, 7 weeks old, female) 0.2 ml subcutaneously on the back
Each was administered. After the first immunization, booster immunization was performed on the 7th and 16th days, and further 3 days before cell fusion, a human hemoglobin solution was intraperitoneally administered at 0.25 mg / 0.2 ml.
Mouse spleen cells and myeloma cells (P3x63-Ag-6,5,3) on the third day after the final immunization were fused at a ratio of 10: 1 with 50% polyethylene glycol 4000 and selected by HAT medium. On the 14th day after cell fusion, the antibody activity against human hemoglobin in the culture supernatant was measured by EI.
It was measured by Method A. The measurement method is human hemoglobin 10
A 96-well EIA plate (manufactured by Coaster) immobilized at 0 μg / ml was used, and 200 μl of a culture solution of the fused cells was added. Then, after reacting at 37 ° C. for 1 hour, washing was performed and peroxidase-labeled anti-mouse IgG (manufactured by Cappel,
200 μl of 1: 500) was added. After washing, a substrate solution (0.1 M O -phenylenediamine and 0.012% hydrogen peroxide solution) was added to each well in an amount of 200 μl and reacted at room temperature for 5 minutes. After the reaction, add 50 N of 4N sulfuric acid to each well.
The enzyme reaction was stopped by adding μl each. Next, the absorbance value at 492 nm was measured, and the clone reacting with human hemoglobin was cloned twice by the limiting dilution method.
As a result, 10 monoclonal antibodies were obtained as ascites fluid after cloning. 1 ml of each of these obtained ascites was diluted 2-fold with 1 ml of PBS, 2 ml of saturated ammonium sulfate was added dropwise, and the mixture was left at 4 ° C. for 4 hours. Then, the mixture was centrifuged at 3,000 rpm for 20 minutes, and the precipitate was suspended in 2 ml of PBS (phosphate buffered saline) and dialyzed. Of these, two clones with high reactivity (K-
6, K-8) was selected and used in the following tests. The immunoglobulin subclasses of 2 clones are IgG 1 , L
The chains were kappa type.
【0028】(2)抗体固相化支持体の作製 ニトロセルロースシート(BAS−85,Schlei
cher & Schuell社製)を5mm×50m
mに裁断し、その下端より10mmの位置に抗ヒトヘモ
グロビンモノクロナール抗体溶液0.5mg/ml(K
−6),15mmの位置に抗ヒトトランスフェリンモノ
クロナール抗体溶液0.5mg/ml(ケミコン社
製)、20mmの位置に抗ウサギIgGポリクロナール
抗体溶液0.5mg/ml(Cappel社製)を各々
エアーブラシ(オリンポス社製)を用いて塗布し、抗ヒ
トヘモグロビン抗体と抗ヒトトランスフェリン抗体およ
び抗ウサギIgG抗体のラインを作製した。室温で2時
間乾燥後、1%スキムミルク(DIFCO社製)−0.
1%ツィーン20を含むPBSに37℃、2時間浸漬し
マスキングを行った。その後、充分に乾燥し抗体固相化
支持体を作製した。(2) Preparation of antibody-immobilized support Nitrocellulose sheet (BAS-85, Schlei)
cher & Schuell) 5mm x 50m
m, and at the position 10 mm from the lower end, 0.5 mg / ml of anti-human hemoglobin monoclonal antibody solution (K
-6), 0.5 mg / ml anti-human transferrin monoclonal antibody solution (Chemicon) at 15 mm position, 0.5 mg / ml anti-rabbit IgG polyclonal antibody solution (Cappel) at 20 mm position, respectively. (Manufactured by Olympus Co., Ltd.) to apply a line of anti-human hemoglobin antibody, anti-human transferrin antibody, and anti-rabbit IgG antibody. After drying at room temperature for 2 hours, 1% skim milk (manufactured by DIFCO) -0.
Masking was performed by immersing in PBS containing 1% Tween 20 at 37 ° C. for 2 hours. Then, it was sufficiently dried to prepare an antibody-immobilized support.
【0029】(3)着色ラテックス粒子標識物の調製 a.レッドラテックス粒子標識抗ヒトヘモグロビン抗体 レッドラテックス粒子分散液(PL−Latex,10
%,450nm,Polymer Laborator
ies社製)300μlにPBS1.2mlを加え、1
3,000rpm,5分間遠心分離を行った。沈査に抗
ヒトヘモグロビンモノクロナール抗体溶液(0.5mg
/ml)(K−8)1mlを加え、充分混和して、室温
1時間反応を行った。未反応の抗ヒトヘモグロビンモノ
クロナール抗体を除去するため、13,000rpm,
5分間遠心分離を行い、沈査をPBS1.5mlに懸濁
し、再度遠心分離を行った。4%ブロックエース(明治
乳業社製)1mlを加え、室温60分間反応させてマス
キングを行った。その後、13,000rpm,5分間
遠心分離を行い、沈査を1%スキムミルク−0.01%
アジ化ナトリウムを含むPBS1.5mlに懸濁し冷蔵
保存した。 b.グリーンラテックス粒子標識抗ヒトトランスフェリ
ン抗体 グリーンラテックス粒子分散液(PL−Latex,1
0%,450nm,Polymer Laborato
ries社製)および抗ヒトトランスフェリンモノクロ
ナール抗体(0.5mg/ml,アドバンス イムノケ
ミカル社製)を用いて上記と同様な操作で調製した。 c.ブルーラテックス粒子標識ウサギIgG ブルーラテックス粒子分散液(PL−Latex,10
%,450nm,Polymer Laborator
ies社製)およびウサギIgG(0.5mg/ml,
Cappel社製)を用いて上記と同様な操作で調製し
た。 d.着色ラッテクス粒子標識物凍乾担体 それら3種類の着色ラテックス粒子標識物を等量混和
し、ベンリーゼ(登録商標)不織布(旭化成社製)5m
m×5mmに10μl含浸させ凍結乾燥をして調製し
た。(3) Preparation of colored latex particle label a. Red latex particle-labeled anti-human hemoglobin antibody Red latex particle dispersion (PL-Latex, 10
%, 450 nm, Polymer Laborator
1.2 ml of PBS was added to 300 μl of 1)
Centrifugation was performed at 3,000 rpm for 5 minutes. Anti-human hemoglobin monoclonal antibody solution (0.5 mg
/ Ml) (K-8) (1 ml) was added, mixed well, and reacted at room temperature for 1 hour. To remove unreacted anti-human hemoglobin monoclonal antibody, 13,000 rpm,
After centrifugation for 5 minutes, the precipitate was suspended in 1.5 ml of PBS and centrifuged again. 1 ml of 4% Block Ace (manufactured by Meiji Dairy Co., Ltd.) was added, and the reaction was carried out at room temperature for 60 minutes for masking. After that, centrifugation was performed at 13,000 rpm for 5 minutes, and sedimentation was performed with 1% skim milk-0.01%.
The cells were suspended in 1.5 ml of PBS containing sodium azide and stored under refrigeration. b. Green latex particle labeled anti-human transfer
Antibody green latex particle dispersion (PL-Latex, 1
0%, 450nm, Polymer Laborato
RIE) and anti-human transferrin monoclonal antibody (0.5 mg / ml, manufactured by Advance Immunochemical). c. Blue Latex Particle Labeled Rabbit IgG Blue Latex Particle Dispersion (PL-Latex, 10
%, 450 nm, Polymer Laborator
ies) and rabbit IgG (0.5 mg / ml,
(Manufactured by Cappel) was prepared in the same manner as above. d. Colored latex particles labeled freeze-dried carrier These three types of colored latex particles labeled are mixed in equal amounts, and Benliese (registered trademark) non-woven fabric (manufactured by Asahi Kasei Corporation) 5 m
It was prepared by impregnating 10 μl of m × 5 mm and freeze-drying.
【0030】(4)試験片の作製 抗体固相化支持体の下端から2.5mmの位置まで着色
ラテックス標識物凍乾担体を重ねた。さらに、着色ラテ
ックス標識物凍乾担体上に被検液浸漬用担体を下端から
2.5mmの位置まで重ねた。また、抗体固相化支持体
の上端から5mmの位置まで吸水性担体5mm×20m
m(No.526,アドバンテック東洋社製)を重ね、
最後に透明なテープを上部に貼り固定して試験片とし
た。(図1)(4) Preparation of test piece A colored latex labeled lyophilized carrier was piled up to a position 2.5 mm from the lower end of the antibody-immobilized support. Further, a carrier for dipping the test liquid was placed on the freeze-dried carrier for colored latex label up to a position 2.5 mm from the lower end. In addition, a water-absorbent carrier 5 mm x 20 m up to a position 5 mm from the upper end of the antibody-immobilized support
m (No. 526, manufactured by Advantech Toyo Co., Ltd.),
Finally, a transparent tape was attached to the upper part and fixed to obtain a test piece. (Fig. 1)
【0031】(5)標準液を用いた反応性試験 ヒトヘモグロビン(2回結晶、Sigma社製)、ヒト
トランスフェリン(ケミコン社製)を各々100μg/
mlになるように0.1%BSAを含むPBSで溶解し
2種類の標準液を調製した。標準液200μlを試験片
の被検液浸漬用担体に滴加してのち展開した。5分後、
あらかじめ固相化したライン部分の着色の有無により判
定を行った。なお、対照として0.1%BSAを含むP
BSのみを用いて同様に操作した。2種類の標準液を展
開した場合には赤色のライン(ヒトヘモグロビン)、緑
色のライン(ヒトトランスフェリン)青色のライン(イ
ンジケーター物質)が検出された。また、ヒトヘモグロ
ビン標準液では赤色と青色のライン、ヒトトランスフェ
リン標準液では緑色と青色のライン、対照では青色のラ
インのみが検出された。(図2)(5) Reactivity test using a standard solution Human hemoglobin (double crystal, Sigma) and human transferrin (Chemicon) 100 μg / each
Two kinds of standard solutions were prepared by dissolving with PBS containing 0.1% BSA so as to make up to ml. 200 μl of the standard solution was added dropwise to the carrier for immersing the test solution in the test piece, and then developed. 5 minutes later,
Judgment was made based on the presence / absence of coloring of the solid-phased line portion. As a control, P containing 0.1% BSA
The same operation was performed using only BS. When two kinds of standard solutions were developed, a red line (human hemoglobin), a green line (human transferrin) and a blue line (indicator substance) were detected. In addition, only red and blue lines were detected in the human hemoglobin standard solution, green and blue lines were detected in the human transferrin standard solution, and only the blue line was detected in the control. (Fig. 2)
【0032】実施例2 便中ヒトヘモグロビンの検出方
法(試験片) (1)抗体固相化支持体の作製 ニトロセルロースシート(BAS−85,Schlei
cher & Schuell社製)を5mm×50m
mに裁断し、その下端より10mmの位置に抗ヒトヘモ
グロビンモノクロナール抗体溶液0.5mg/ml(K
−6),20mmの位置に抗ウサギIgGポリクロナー
ル抗体溶液0.5mg/ml(Cappel社製)を各
々エアーブラシ(オリンポス社製)を用いて塗布し、抗
ヒトヘモグロビン抗体および抗ウサギIgG抗体のライ
ンを作製した。室温で2時間乾燥後、1%スキムミルク
(DIFCO社製)−0.1%ツィーン20を含むPB
Sに37℃、2時間浸漬しマスキングを行った。その
後、充分に乾燥し抗体固相化支持体を作製した。Example 2 Method for detecting human hemoglobin in feces (test piece) (1) Preparation of antibody-immobilized support Nitrocellulose sheet (BAS-85, Schlei)
cher & Schuell) 5mm x 50m
m, and at the position 10 mm from the lower end, 0.5 mg / ml of anti-human hemoglobin monoclonal antibody solution (K
-6), 0.5 mg / ml of anti-rabbit IgG polyclonal antibody solution (manufactured by Cappel) was applied to the position of 20 mm using an airbrush (manufactured by Olympos), and a line of anti-human hemoglobin antibody and anti-rabbit IgG antibody was applied. Was produced. After drying at room temperature for 2 hours, PB containing 1% skim milk (manufactured by DIFCO) -0.1% Tween 20.
Masking was performed by immersing in S at 37 ° C. for 2 hours. Then, it was sufficiently dried to prepare an antibody-immobilized support.
【0033】(2)着色ラテックス粒子標識物の調製 レッドラテックス粒子標識抗ヒトヘモグロビン抗体およ
びブルーラテックス粒子標識ウサギIgGは実施例1で
調製した各々の標識ラテックス粒子を使用した。着色ラテックス粒子標識物凍乾担体 それら2種類の着色ラテックス粒子標識物を等量混合
し、ベンリーゼ(登録商標)不織布(旭化成社製)5m
m×5mmに10μl含浸させ凍結乾燥をして調製し
た。 (3)試験片の作製 実施例1と同様に作製した。(2) Preparation of Colored Latex Particle Labeled Product Red latex particle labeled anti-human hemoglobin antibody and blue latex particle labeled rabbit IgG used each labeled latex particle prepared in Example 1. Colored latex particle labeled material Lyophilized carrier These two types of colored latex particle labeled materials were mixed in equal amounts, and Benliese (registered trademark) non-woven fabric (manufactured by Asahi Kasei) 5 m
It was prepared by impregnating 10 μl of m × 5 mm and freeze-drying. (3) Preparation of test piece It was prepared in the same manner as in Example 1.
【0034】(4)標準液を用いた反応性試験 ヒトヘモグロビン(2回結晶、Sigma社製)を各々
1mg/ml,1μg/ml,100ng/ml,10
ng/mlになるように0.1%BSAを含むPBSで
溶解し標準液を調製した。標準液200μlを試験片の
被検液浸漬用担体に滴加してのち展開した。なお、対照
として0.1%BSAを含むPBSを用いて同様に操作
した。ヒトヘモグロビン濃度が100ng/mlまで赤
色のラインを検出した。また、インジケーター物質であ
るウサギIgGのラインは全例検出された。なお、試験
結果を表1に示した。(4) Reactivity test using a standard solution Human hemoglobin (2 times crystal, manufactured by Sigma) was 1 mg / ml, 1 μg / ml, 100 ng / ml, 10 respectively.
A standard solution was prepared by dissolving with PBS containing 0.1% BSA so that the concentration became ng / ml. 200 μl of the standard solution was added dropwise to the carrier for immersing the test solution in the test piece, and then developed. The same operation was performed using PBS containing 0.1% BSA as a control. A red line was detected up to a human hemoglobin concentration of 100 ng / ml. In addition, the line of rabbit IgG, which is an indicator substance, was detected in all cases. The test results are shown in Table 1.
【0035】[0035]
【表1】 [Table 1]
【0036】(5)糞便中のヒトヘモグロビン検出試験 便潜血陰性便にヒトヘモグロビンを便1gあたり1,
0.1,0.05,0.01mgを添加し、よく混和し
た。次に各ヒトヘモグロビン添加便を10mgずつ採取
して、各々0.005%ツィーン20−0.1%BSA
を含むPBS2mlに懸濁し、よく混和後、スポンジで
すばやく濾過した液を便懸濁液とした。便懸液200μ
lを被検液浸漬用担体に滴加してのち展開した。ヒトヘ
モグロビン無添加便も対照として同様の測定を行った。
ヒトヘモグロビン添加便は0.05mg/g濃度まで赤
色のラインが検出された。また、インジケーター物質で
あるウサギIgGの青色のラインは全例検出された。な
お、試験結果を表2に示した。(5) Human Hemoglobin Detection Test in Feces Human hemoglobin was added to fecal occult blood negative stools at 1 / g of stool.
0.1, 0.05 and 0.01 mg were added and mixed well. Next, 10 mg of each human hemoglobin-containing stool was collected, and 0.005% Tween 20-0.1% BSA was collected.
The suspension was suspended in 2 ml of PBS containing the above, mixed well, and then quickly filtered with a sponge to give a fecal suspension. Stool suspension 200μ
1 was added dropwise to the carrier for immersing the test liquid and then developed. The same measurement was performed for human hemoglobin-free stool as a control.
In human hemoglobin-added feces, a red line was detected up to a concentration of 0.05 mg / g. In addition, the blue line of rabbit IgG, which is the indicator substance, was detected in all cases. The test results are shown in Table 2.
【0037】[0037]
【表2】 [Table 2]
【0038】実施例3 便中ヒトヘモグロビンの検出法
(一体型簡易測定装置を用いた測定) (1)一体型簡易測定装置の作製 本装置は検体溶解部(31)、検体採取部(32)、検
出部(33)から構成されている。検体溶解部(31)
には溶解液(34)(0.1%BSA−0.005%ツ
ィーン20を含むPBS)2mlを加え、開口部は液漏
れを生じないようにアルミ製基材のシールで完全に接着
した。検出部(33)は上下に2分割できる構造であ
り、この中に実施例1で作製した試験片を装着した。次
に検体採取部(32)の検出部(33)側の開口部のと
ころに、検体溶解液吸収性担体(37)として5mm×
30mmに裁断した濾紙(No.526、アドバンテッ
ク東洋社製)を挿入した。連結部(38)を介して、検
出部(33)と検体採取部(32)を連結して検体採取
可能な装置とした。Example 3 Method of Detecting Human Hemoglobin in Feces (Measurement by Using Integrated Simple Measuring Device) (1) Preparation of Integrated Simple Measuring Device This device is a sample dissolving part (31) and a sample collecting part (32). , A detection unit (33). Specimen dissolution section (31)
The solution (34) (PBS containing 0.1% BSA-0.005% Tween 20) (2 ml) was added to and the opening was completely adhered by a seal of an aluminum base material so as to prevent liquid leakage. The detection part (33) has a structure that can be divided into two parts up and down, and the test piece prepared in Example 1 was mounted therein. Next, at the opening of the sample collecting part (32) on the side of the detecting part (33), 5 mm × as a sample solution absorbing carrier (37)
A filter paper (No. 526, manufactured by Advantech Toyo Co., Ltd.) cut into 30 mm was inserted. The detection unit (33) and the sample collection unit (32) were connected via the connection unit (38) to provide a device capable of collecting a sample.
【0039】(2)検査法 検体採取仕様の検体採取部(32)側で便を数回突き刺
し、検体採取穴(35)に便を入れた。検体採取部(3
2)の先端についた余分な便をトイレットペーパーでふ
きとり、検体溶解部(31)のシールを検体採取部の先
端で破り、検体溶解部(31)と検体採取仕様にしたも
のを連結後、一体型簡易測定装置にして、その装置を上
下に激しく振り便を溶解した。判定部を上にした後、た
だちに一体型簡易測定装置を水平に静置した。この操作
により一定量(200μl)の検体溶解液が取り込み口
より入り、展開・移動して、5分後反応が終了した。そ
の後、検体採取部(32)と検出部(33)の連結部分
から検出部(33)を取り外し結果を判定した。(2) Test Method Feces were pierced several times on the side of the specimen collecting part (32) of the specimen collecting specification, and the feces were put into the specimen collecting hole (35). Sample collection unit (3
Wipe off excess stool attached to the tip of 2) with toilet paper, tear the seal of the sample dissolving part (31) at the tip of the sample collecting part, and connect the sample dissolving part (31) with the sample collection specification, and then A simple body shape measuring device was used, and the device was vigorously shaken up and down to dissolve feces. Immediately after the judgment part was turned up, the integrated simple measuring device was left horizontally horizontally. By this operation, a fixed amount (200 μl) of the sample solution entered through the intake port, developed and moved, and the reaction was completed after 5 minutes. Then, the detection part (33) was removed from the connection part of the sample collection part (32) and the detection part (33), and the result was determined.
【0040】(3)糞便中のヒトヘモグロビン検出試験 便潜血陰性便にヒトヘモグロビンを便1gあたり、各々
1,0.1,0.05,0.01mgを添加し、よく混
和してヒトヘモグロビン添加便を調製した。この添加便
を実施例3(2)の検査法で測定した。なお、表3に示
すように一体型簡易測定装置を用いても、試験片のみの
場合と同じ結果を示した。(3) Human Hemoglobin Detection Test in Feces Human hemoglobin was added to fecal occult blood negative stools at 1, 0.1, 0.05 and 0.01 mg per 1 g of stool, and mixed well to add human hemoglobin Stool was prepared. This added stool was measured by the test method of Example 3 (2). As shown in Table 3, even when using the integrated simple measuring device, the same result as in the case of only the test piece was shown.
【0041】[0041]
【表3】 [Table 3]
【0042】(4)大腸がん患者便の測定 大腸がんと診断された患者の便10例について、一体型
簡易測定装置を用いて測定を行った。なお、対照として
健常者便10例も同様に行った。その結果、大腸がんの
患者便では全例赤色のライン(ヒトヘモグロビン)と青
色のライン(ウサギIgG)が検出され、便潜血陽性と
判定された。また、健常者便では全例青色のライン(ウ
サギIgG)が検出されたのみで便潜血陰性と判定され
た。(4) Measurement of stools of patients with colorectal cancer Ten stools of patients diagnosed with colorectal cancer were measured using an integrated simple measuring device. As a control, 10 healthy stools were also used. As a result, red lines (human hemoglobin) and blue lines (rabbit IgG) were detected in all patients with colorectal cancer, and it was determined that fecal occult blood was positive. In all the stools of healthy subjects, only the blue line (rabbit IgG) was detected, and the fecal occult blood was determined to be negative.
【0043】比較例1 ラテックス法との比較 糞便検体140例を用い、ラテックス凝集法を原理とし
た便中のヘモグロビン測定試薬『OC−ヘモディア』
(登録商標)(栄研化学社製)と一体型簡易測定装置を
用いた便潜血測定法を比較した。表4に示すように14
0例中131例が両方で一致し、一致率は93.6%で
あり良好な結果を示した。Comparative Example 1 Comparison with the latex method Using 140 cases of fecal samples, a reagent "OC-hemodia" for measuring hemoglobin in stool based on the latex agglutination method.
(Registered trademark) (manufactured by Eiken Chemical Co., Ltd.) and a fecal occult blood measurement method using an integrated simple measuring device were compared. 14 as shown in Table 4
131 cases out of 0 cases were coincident in both cases, and the concordance rate was 93.6%, which was a good result.
【0044】[0044]
【表4】 [Table 4]
【0045】比較例2 従来法と本発明による判定結果
の難易性の比較 インジケーターラインと検出すべき物質のラインが異な
る色調の場合(本発明法)と同一の色調である場合(従
来法)に対する判定結果の難易性についてパネラーを無
作為に12名選び比較を行った。 (1)従来法(同一色調)試験片の作製 抗体固相化支持体は実施例2の抗ウサギIgGポリクロ
ナール抗体溶液の代わりに抗マウスIgG抗体(Cap
pel社製)を用いて同様に作製した。一方、ブルーラ
ッテクス粒子標識抗ヒトヘモグロビン抗体は実施例1と
同様に作製した。この粒子をベンリーゼ(登録商標)不
織布(5mm×5mm,旭化成社製)に10μl含浸さ
せ凍結乾燥をして調製した。先の支持体と担体を用いて
実施例1の方法に従って試験片を作製し、実施例2の標
準液を用いて反応性試験を行ったところ、ヒトヘモグロ
ビン濃度が100ng/mlまで青色のラインを検出し
た。また、インジケーターラインは全例青色のラインと
して検出され、本試験片は正常に作動することが判っ
た。Comparative Example 2 Comparison of Difficulty of Judgment Result by Conventional Method and Present Invention For the case where the indicator line and the line of the substance to be detected have different color tones (the method of the present invention) and the same color tone (the conventional method) Regarding the difficulty of the judgment result, 12 panelists were randomly selected and compared. (1) Preparation of test piece by conventional method (same color tone) The antibody-immobilized support was prepared by using an anti-mouse IgG antibody (Cap) instead of the anti-rabbit IgG polyclonal antibody solution of Example 2.
(manufactured by pel) was similarly prepared. On the other hand, a blue latex particle-labeled anti-human hemoglobin antibody was prepared in the same manner as in Example 1. The particles were prepared by impregnating 10 μl of Benlyse (registered trademark) non-woven fabric (5 mm × 5 mm, manufactured by Asahi Kasei Co., Ltd.) and freeze-drying. A test piece was prepared according to the method of Example 1 using the above support and carrier, and a reactivity test was performed using the standard solution of Example 2. As a result, a blue line was obtained up to a human hemoglobin concentration of 100 ng / ml. Detected. In addition, the indicator line was detected as a blue line in all cases, and it was found that this test piece operates normally.
【0046】(2)本発明による方法と従来法の着色試
験片の作製 実施例2で作製した本発明の試験片と従来法の試験片に
各々ヒトヘモグロビン標準液(1μg/ml、0.1%
BSAを含むPBSで溶解)を実施例2(4)の方法に
従って反応せしめ、両法による着色試験片を各々作製し
た。(2) Preparation of Colored Specimen by Method According to the Present Invention and Conventional Method The test pieces of the present invention and the conventional method prepared in Example 2 were prepared with human hemoglobin standard solution (1 μg / ml, 0.1, respectively). %
(Dissolved in PBS containing BSA) was reacted according to the method of Example 2 (4) to prepare colored test pieces by both methods.
【0047】(3)本発明による方法と従来法による判
定結果に対する難易性の比較 両法の判定結果に対する難易性を比較するため、パネラ
ー12名(女性5名含む)を任意に選出し、2点嗜好試
験法による官能検査(「官能検査ハンドブック」日科技
連官能検査委員会(編)、1985)に準拠して判定を
行った。表5に示したように本検査に準拠した方法か
ら、12名ともに本発明による方法の方が「判定しやす
い」との回答が得られ、明らかに本発明の方法が優れて
いた。(3) Comparison of Difficulty of Judgment Results by the Method According to the Present Invention and Conventional Method In order to compare the difficulty of judgment results by both methods, 12 panelists (including 5 females) were arbitrarily selected and 2 The judgment was made in accordance with the sensory test by the point preference test method ("Sensory Test Handbook", Nikkan Giren Sensory Test Committee (ed.), 1985). As shown in Table 5, from the methods conforming to the present inspection, all 12 persons answered that the method according to the present invention was “easier to judge”, and the method of the present invention was clearly superior.
【0048】[0048]
【表5】 [Table 5]
【0049】[0049]
【発明の効果】本発明によれば、色調の異なる標識ラテ
ックス粒子を用い、イムノクロマトグラフィーによって
複数の物質を目視的に別々の色調で同時に検出すること
ができる。本発明による簡易型の測定装置を提供するこ
とによって、例えば、一般用医薬品としての体外診断薬
に応用すれば、いつでも、どこでも、誰にでも容易に実
施することができる。さらに、検査結果の判定には色調
の異なるラテックス粒子を用いていることから、間違う
ことなく明確に判定できることが特徴である。また、本
簡易測定装置は連結可能な一体型の装置として考案して
いるので、検査終了後、すみやかに検出部品のみを切り
離し、回収して検査機関や病院へ郵送したり、届けたり
することができる。このように本装置はきわめて衛生的
である、また医療従事者に対するバイオハザードの面か
らも極めて優れた装置を提供するものである。INDUSTRIAL APPLICABILITY According to the present invention, a plurality of substances can be visually detected simultaneously in different colors by immunochromatography using labeled latex particles having different colors. By providing the simplified measuring device according to the present invention, for example, when it is applied to an in-vitro diagnostic drug as an over-the-counter drug, it can be easily performed by anyone, anytime, anywhere. Further, since latex particles having different color tones are used for the determination of the inspection result, it is possible to make a clear determination without making a mistake. In addition, since this simple measuring device was devised as a unitary device that can be connected, it is possible to disconnect only the detection parts promptly after the inspection, collect them, and mail or deliver them to the inspection organization or hospital. it can. As described above, the present device is extremely hygienic and provides an extremely excellent device for medical personnel in terms of biohazard.
【図1】本発明の試験片の1態様を示したものであり、
該試験片上部図および断面図である。1 shows one embodiment of a test piece of the present invention,
It is the test piece top view and sectional drawing.
【図2】本発明の方法を用いた測定結果の1態様を示し
たものであり、ヒトヘモグロビン、ヒトトランスフェリ
ンを同時に検出、測定した結果である。FIG. 2 shows one embodiment of measurement results using the method of the present invention, which is the result of simultaneous detection and measurement of human hemoglobin and human transferrin.
【図3】本発明は連結一体型簡易測定装置の1態様を示
したものであり、一体型(全体図)、検体採取仕様(断
面図、上部図)、測定仕様(上部図)である。FIG. 3 is a view showing one embodiment of a connection-integrated type simple measurement device, which is an integrated type (overall view), sample collection specifications (cross-sectional view, upper view), and measurement specifications (upper view).
1 吸収性担体 2 抗体固相化支持体 3 着色ラテックス粒子標識物凍乾担体 4 被検液浸漬用担体 5 抗ウサギIgG抗体固相化ゾーン 6 抗ヒトトランスフェリン抗体固相化ゾーン 7 抗ヒトヘモグロビン抗体固相化ゾーン 21 ヒトヘモグロビン標準液とヒトトランスフェリ
ン標準液の混合液を展開したクロマトグラム 22 ヒトヘモグロビン標準液を展開したクロマトグ
ラム 23 ヒトトランスフェリン標準液を展開したクロマ
トグラム 24 対照を展開したクロマトグラム 31 検体溶解部 32 検体採取部 33 検出部 34 溶解液 35 検体採取穴 36 検体溶解液取り込み口 37 検体溶解液吸収性担体 38 連結部 39 試験片 40 判定窓1 Absorbable carrier 2 Antibody-immobilized support 3 Colored latex particle label Freeze-dried carrier 4 Carrier for immersion of test liquid 5 Anti-rabbit IgG antibody-immobilized zone 6 Anti-human transferrin antibody-immobilized zone 7 Anti-human hemoglobin antibody Immobilization zone 21 Chromatogram developed with a mixture of human hemoglobin standard solution and human transferrin standard solution 22 Chromatogram developed with human hemoglobin standard solution 23 Chromatogram developed with human transferrin standard solution 24 Chromatogram developed with control 31 Specimen dissolution part 32 Specimen sampling part 33 Detection part 34 Lysis solution 35 Specimen collection hole 36 Specimen dissolution solution intake port 37 Specimen dissolution solution absorbent carrier 38 Coupling part 39 Test piece 40 Judgment window
───────────────────────────────────────────────────── フロントページの続き (72)発明者 若杉 昌彦 東京都中央区日本橋室町1−5−3 わか もと製薬株式会社内 (72)発明者 松山 恵理子 東京都中央区日本橋室町1−5−3 わか もと製薬株式会社内 (72)発明者 前田 孚 東京都中央区日本橋室町1−5−3 わか もと製薬株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Masahiko Wakasugi 1-5-3 Nihombashi Muromachi, Chuo-ku, Tokyo Inside Wakamoto Pharmaceutical Co., Ltd. (72) Inventor Eriko Matsuyama 1-5-3 Nihonbashi Muromachi, Chuo-ku, Tokyo Inside Wakamoto Pharmaceutical Co., Ltd. (72) Inventor Takeshi Maeda 1-5-3 Nihombashi Muromachi, Chuo-ku, Tokyo Inside Wakamoto Pharmaceutical Co., Ltd.
Claims (5)
ス粒子を用いる免疫学的測定方法において、 a.あらかじめ、2種類以上の色調の異なる着色ラテッ
クス粒子をインジケーター物質および1種類以上の免疫
学的反応に授かる物質に各々個別に標識せしめ、 b.一方、同一支持体上の異なる位置に少なくとも2種
類以上からなる免疫学的に反応する能力のある物質を、
あらかじめ固相化し、 c.ついでインジケーター物質および1種類以上の免疫
学的反応に授かる物質からなる標識着色ラテックス粒子
の混合物と被検液中の特定の少なくとも1種類以上の免
疫学的物質と反応せしめ、 d.ついで、インジケーター物質を標識した着色ラテッ
クス粒子と免疫学的に形成させた標識着色ラテックス複
合体との混合物に、被検液を媒体として展開・移動せし
め、 e.2種類以上の免疫学的に反応する能力を有する物質
をあらかじめ固相化しておいた複数の位置に、それぞれ
対応するインジケーター物質を標識せしめた着色ラテッ
クス粒子と免疫学的に形成せしめた標識着色ラテックス
複合体によって、別々の色調で着色することを特徴とす
る免疫学的測定方法。1. An immunological measuring method using two or more kinds of colored latex particles having different color tones, comprising: a. In advance, two or more types of colored latex particles having different color tones are individually labeled with an indicator substance and one or more types of substances that are involved in immunological reaction, respectively. B. On the other hand, at least two kinds of substances capable of immunologically reacting at different positions on the same support,
Immobilized in advance, c. Then, a mixture of labeled colored latex particles comprising an indicator substance and one or more substances that are involved in an immunological reaction and at least one specific immunological substance in a test liquid are reacted, and d. Then, the test solution is developed and moved to a mixture of the colored latex particles labeled with the indicator substance and the labeled colored latex complex immunologically formed, and e. Colored latex particles labeled with corresponding indicator substances at a plurality of positions on which solidified substances having two or more immunological reactivities have been immobilized in advance and labeled colored latex immunologically formed. An immunological measuring method, characterized in that the complex is colored in different colors.
ロビンである請求項1の方法。2. The method according to claim 1, wherein the specific immunological substance in the test liquid is hemoglobin.
験片。3. A test piece according to the method of claims 1 and 2.
能部品からなり、必要に応じて各機能部品を一体化ある
いは連結できる簡易測定装置であって、 a.採取が採取部品と検出部品の連結によって達成さ
れ、 b.採取後の検体の溶解と溶解液の一定量のサンプリン
グおよび免疫学的反応が検体溶解部品、採取部品、検出
部品の一体化あるいは連結によって達成され、 c.免疫学的反応終了後、検出部品を切り離すことので
きる簡易測定装置。4. A simple measuring device comprising three functional parts including a sample dissolving part, a sample collecting part, and a detecting part, and each functional part can be integrated or connected as necessary, comprising: a. Harvesting is accomplished by coupling the harvesting component and the sensing component, b. Dissolution of the sample after collection and a fixed amount of sampling and immunological reaction are achieved by integrating or linking the sample dissolution component, the collection component, and the detection component, c. A simple measuring device that can separate the detection parts after completion of immunological reaction.
求項3の試験片を内蔵する簡易測定装置。5. A simple measuring device incorporating the test piece according to claim 3 by the method according to claim 1 and claim 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25605394A JP3304214B2 (en) | 1994-09-27 | 1994-09-27 | Simple measuring method and simple measuring device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25605394A JP3304214B2 (en) | 1994-09-27 | 1994-09-27 | Simple measuring method and simple measuring device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0894618A true JPH0894618A (en) | 1996-04-12 |
| JP3304214B2 JP3304214B2 (en) | 2002-07-22 |
Family
ID=17287253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25605394A Expired - Fee Related JP3304214B2 (en) | 1994-09-27 | 1994-09-27 | Simple measuring method and simple measuring device |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3304214B2 (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998040740A1 (en) * | 1997-03-10 | 1998-09-17 | Nissui Pharmaceutical Co., Ltd. | Analytical method, kit, and apparatus |
| WO1999021012A1 (en) * | 1997-10-21 | 1999-04-29 | Sekisui Chemical Co., Ltd. | Colored latex |
| WO2000079278A1 (en) * | 1999-06-18 | 2000-12-28 | Matsushita Electric Industrial Co., Ltd. | Chromatographic analyzer |
| JP2006189317A (en) * | 2005-01-06 | 2006-07-20 | Sysmex Corp | Testing element for immunochromatographic method |
| JP2006194688A (en) * | 2005-01-12 | 2006-07-27 | Sysmex Corp | Kit for immuno-chromatography |
| JP2006266764A (en) * | 2005-03-22 | 2006-10-05 | Kobayashi Pharmaceut Co Ltd | Menopause stage determination implement |
| JP2011502260A (en) * | 2007-10-30 | 2011-01-20 | ジョン ワン、 | Method and apparatus for detecting occult blood |
| WO2011125877A1 (en) * | 2010-03-31 | 2011-10-13 | 積水メディカル株式会社 | Measurement method using immunochromatography, test strip for immunochromatography, and measurement reagent kit for immunochromatography |
| WO2016175336A1 (en) * | 2015-04-27 | 2016-11-03 | デンカ生研株式会社 | Immunochromatography device having reduced background noises, and method for reducing background noises in immunochromatographty device |
| JP2019070670A (en) * | 2019-01-18 | 2019-05-09 | デンカ生研株式会社 | Immunochromatography device with reduced background noise and reduction method thereof |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008014751A (en) * | 2006-07-05 | 2008-01-24 | Denka Seiken Co Ltd | Membrane assay and kit using colored latex particles |
| JP2012083370A (en) * | 2012-01-31 | 2012-04-26 | Denka Seiken Co Ltd | Membrane assay method and kit using colored latex particle |
| WO2014007384A1 (en) * | 2012-07-05 | 2014-01-09 | 日本碍子株式会社 | Sample testing member |
| JP2014098715A (en) * | 2014-02-12 | 2014-05-29 | Denka Seiken Co Ltd | Membrane assay method and kit using colored latex particle |
-
1994
- 1994-09-27 JP JP25605394A patent/JP3304214B2/en not_active Expired - Fee Related
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998040740A1 (en) * | 1997-03-10 | 1998-09-17 | Nissui Pharmaceutical Co., Ltd. | Analytical method, kit, and apparatus |
| US6448001B2 (en) | 1997-03-10 | 2002-09-10 | Nissui Pharmaceutical Co., Ltd. | Analytical method, kit, and apparatus |
| WO1999021012A1 (en) * | 1997-10-21 | 1999-04-29 | Sekisui Chemical Co., Ltd. | Colored latex |
| WO2000079278A1 (en) * | 1999-06-18 | 2000-12-28 | Matsushita Electric Industrial Co., Ltd. | Chromatographic analyzer |
| JP2006189317A (en) * | 2005-01-06 | 2006-07-20 | Sysmex Corp | Testing element for immunochromatographic method |
| US7993935B2 (en) | 2005-01-06 | 2011-08-09 | Sysmex Corporation | Test strip for immunochromatography |
| JP2006194688A (en) * | 2005-01-12 | 2006-07-27 | Sysmex Corp | Kit for immuno-chromatography |
| JP2006266764A (en) * | 2005-03-22 | 2006-10-05 | Kobayashi Pharmaceut Co Ltd | Menopause stage determination implement |
| JP2011502260A (en) * | 2007-10-30 | 2011-01-20 | ジョン ワン、 | Method and apparatus for detecting occult blood |
| CN103069277A (en) * | 2010-03-31 | 2013-04-24 | 积水医疗株式会社 | Measurement method using immunochromatography, test strip for immunochromatography, and measurement reagent kit for immunochromatography |
| WO2011125877A1 (en) * | 2010-03-31 | 2011-10-13 | 積水メディカル株式会社 | Measurement method using immunochromatography, test strip for immunochromatography, and measurement reagent kit for immunochromatography |
| JPWO2011125877A1 (en) * | 2010-03-31 | 2013-07-11 | 積水メディカル株式会社 | Measuring method using immunochromatography, test strip for immunochromatography and measuring reagent kit for immunochromatography |
| US9903865B2 (en) | 2010-03-31 | 2018-02-27 | Sekisui Medical Co., Ltd. | Assay, immunochromatographic test strip, and assay reagent kit for measuring an analyte, using a hematocrit correction |
| WO2016175336A1 (en) * | 2015-04-27 | 2016-11-03 | デンカ生研株式会社 | Immunochromatography device having reduced background noises, and method for reducing background noises in immunochromatographty device |
| JP2016206117A (en) * | 2015-04-27 | 2016-12-08 | デンカ生研株式会社 | Immunochromatography apparatus with reduced background noise and method for reducing the same |
| KR20170139043A (en) * | 2015-04-27 | 2017-12-18 | 덴카 세이켄 가부시키가이샤 | Immunochromatographic apparatus with background noise reduced and method for reducing the same |
| US10900970B2 (en) | 2015-04-27 | 2021-01-26 | Denka Company Limited | Immunochromatographic device reduced in background noise and method for reduced background noise |
| KR20230044032A (en) * | 2015-04-27 | 2023-03-31 | 덴카 주식회사 | Immunochromatography device having reduced background noises, and method for reducing background noises in immunochromatographty device |
| KR20230125850A (en) * | 2015-04-27 | 2023-08-29 | 덴카 주식회사 | Immunochromatography device having reduced background noises, and method for reducing background noises in immunochromatographty device |
| JP2019070670A (en) * | 2019-01-18 | 2019-05-09 | デンカ生研株式会社 | Immunochromatography device with reduced background noise and reduction method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3304214B2 (en) | 2002-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3299330B2 (en) | Simple measuring device and method | |
| EP1003037B1 (en) | Analytical test device and method of use | |
| EP0987550B1 (en) | Analytical test device and method of use | |
| JP4851321B2 (en) | Diagnostic tests for analytes in samples | |
| DK160108C (en) | Method and equipment for direct or indirect detection of reaction between a specific binding agent and the corresponding acceptor substance | |
| EP0319294B1 (en) | Improved membrane assay using focused sample application | |
| US6048735A (en) | Sensor laminates and multi-sectioned fluid delivery devices for detecting by immunoassay target molecules in biological fluids | |
| US7344893B2 (en) | Immuno-gold lateral flow assay | |
| EP0310406A2 (en) | Directed flow diagnostic device and method | |
| JP3304214B2 (en) | Simple measuring method and simple measuring device | |
| FI60935B (en) | FOERFARANDE FOER KONCENTRERING OCH RENING AV ETT URIN- OCH SERUMPROV FOER BESTAEMNING AV HCG ELLER DESS BETA-UNDERENHET IMMUNOLOGISKT OCH I FOERFARANDET ANVAENDBAR ANORDNING | |
| JPS6325553A (en) | Immunological analysis method | |
| AU2003274629B2 (en) | Diagnostic devices | |
| RU2456619C2 (en) | Method and device for detecting minor cell populations in heterogenous cell populations | |
| JPH0216451A (en) | Apparatus for supplying diagnosing device with fluid specimen | |
| GB1597345A (en) | Diagnostic immunochemical test materials and procedure | |
| JPH09500962A (en) | Testing equipment | |
| EP0756173A1 (en) | Reagent for detecting substances and method for diagnosing rheumatoid arthritis | |
| AU625344B2 (en) | Chlamydia half-sandwich immunoassay | |
| CN114544979A (en) | Blood detection kit for early-stage rapid pregnancy diagnosis of yaks | |
| JP2002214236A (en) | Blood antigen detection method and device | |
| JPH085635A (en) | Immunological detection method | |
| JPH05312809A (en) | Immunological simple measurement method and device | |
| JPH04161853A (en) | Simple analytical methods and instruments | |
| WO2012015327A1 (en) | Test system for determining a heart-type fatty acid-binding protein and troponin i (variants) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090510 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090510 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100510 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 8 Free format text: PAYMENT UNTIL: 20100510 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 9 Free format text: PAYMENT UNTIL: 20110510 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 9 Free format text: PAYMENT UNTIL: 20110510 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110510 Year of fee payment: 9 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120510 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 10 Free format text: PAYMENT UNTIL: 20120510 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20130510 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130510 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130510 Year of fee payment: 11 |
|
| R255 | Notification of exclusion from application |
Free format text: JAPANESE INTERMEDIATE CODE: R2525 |
|
| LAPS | Cancellation because of no payment of annual fees |